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tnder what circumstances should a transient childhood
llness be considered a lifelong potential cardiac risk factor?
o all patients who have had Kawasaki disease (KD) require
pecial follow-up, intermittent cardiac testing, and preven-
ive measures beyond the American Heart Association
AHA) recommendations for all Americans? If not, which
atients are at significant risk for late coronary events to
ustify being placed in a high-risk category? These are the
uestions that must be answered to recommend a careful
ollow-up régime for those who are at risk and to reassure
he others. The impact of carrying a lifetime diagnosis of high
otential coronary involvement cannot be underestimated.
It has been 42 years since Tomisaku Kawasaki described
he disease that carries his name (1). Although most of the
eported cases and follow-up studies of children who have
ad KD (1) have been described in Japan, the disease is now
ecognized to be commonplace throughout the world. It is
stimated that there are 10,000 new cases per year in Japan
lone (2) and 4,000 in the U.S. (3). Considering the rest of
he world, it is not unreasonable to estimate that there may
e as many as 1,000,000 patients worldwide, (diagnosed and
ndiagnosed) who have had the disease since it was first
escribed in 1967. In addition, it is reasonable to assume
hat many undiagnosed patients were affected before that
ime.
Among the vast cohort of KD survivors, it is important to
etermine which patients have residual coronary abnormal-
ties that are known to be associated with late cardiovascular
vents. To make this determination, the level of initial
oronary involvement must be considered, that is, in de-
cending order of significance, patients who had giant
neurysms (8 mm), large aneurysms (6 to 8 mm), smaller
neurysms (persistent or regressed), transient coronary di-
ation, and, finally, those who had no discernable coronary
nvolvement at the time of diagnosis.
Persistent giant aneurysms are associated with a high risk
or late complications, including thrombosis, stenosis, and
alcification, potentially leading to myocardial infarction
nd significant late mortality. Although at apparent less risk,
atients with large aneurysms initially, also have been re-a
rom Columbia University Medical Center, New York, New York.
Manuscript received June 18, 2009, accepted June 22, 2009.orted to have angiographic coronary findings later in life.
here is no controversy that these patients will require
ollow-up, testing, and management. Fortunately, individ-
als with residual giant or large aneurysms represent1% of
atients who have had KD (4,5). In a recent multicenter
tudy by the Pediatric Heart Network in the U.S. (5), among
95 carefully observed patients with acute KD, 4 (2%) patients
ad echocardiography evidence of aneurysms, only one of
hom had an aneurysm with a maximal diameter exceeding 6
m. None had giant aneurisms (8 mm).
Patients with well-defined but small aneurysms during KD
epresent the vast majority of those who had coronary
neurysms during the acute illness but are still a small
inority of the total KD population. In recent years, since
arly intravenous immunoglobulin (IVIG) therapy has been
tandard, there have been fewer such patients (5,6) Approx-
mately one-half of small aneurysms will regress with time.
o determine the risk level for late coronary events for these
atients, an attempt must be made to extract these cases
rom large follow-up KD studies documenting late deaths
r complications that are almost always associated with
iant aneurysms. Unfortunately, in many of these reports,
he early status of the coronary arteries may not be empha-
ized or even specified. Thus, when a study indicates that
he risk level for late mortality or morbidity is significant for
atients who had aneurysms during the acute phase of KD,
t is often not known whether this would be true if the
bvious high-risk patients with giant/large aneurysms were
ot included.
Nakamura et al. (7) reported up to 17 years’ follow-up of
,576 patients who had KD from 52 collaborating hospitals
n Japan. Beyond the acute phase, the rate of mortality was
ot increased compared with the expected number of deaths
alculated from Japanese vital statistical data. There were 18
atal cases. Of these, 2 died with “coronary insufficiency,”
ne at 11 months of age and the other at 6 years. In 2 cases,
D was suspected, but not proven to be a factor. The
emaining deaths were not related to KD. The authors of
his study did not include morbidity, and there are no data
egarding the status of the coronary arteries in this popula-
ion during their acute illnesses.
From 1977 to 2005, Tsuda et al. (8) described 19 deathsmong 580 patients followed after KD, 12 having died
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The Risk of Late Coronary Events November 17, 2009:1921–3uddenly (defined as within 24 h of a precipitating event).
he ages ranged from 16 months to 27 years with a median
f 16 years. Two of the 19 died of noncardiac causes. The
thers had severe multivessel coronary disease previously
emonstrated on angiography; 6 had a history of myocardial
nfarction. Three young adults who were known to have
evere coronary disease since infancy were the only deaths
ince 1999. The patients described in this study had KD
efore the IVIG era and clearly represent the most severe
ases. There were no deaths in patients who did not have
nown severe coronary disease. Late mortality or morbidity
rom coronary disease in patients who had small persistent
r regressed aneurysms was not reported.
In the present era, 94% to 98% of patients who had KD
uring the last 25 years did not have aneurysms, including
0% to 85% before the advent of IVIG treatment (4,6). A
eview of the large follow-up studies of KD indicates that
atients who had transient coronary dilation or normal
oronaries during the acute illness have not been shown to
ave late coronary artery complications (6,9). Dilation
sually regresses during the first weeks after the acute
llness, and the authors of follow-up studies have indicated
hat the coronaries remain normal by echocardiographic and
ngiographic criteria. Japanese investigators (6,9) have
greed to classify these patients as having normal coronary
rteries. There are no follow-up studies that describe late
ardiac events associated with the original KD.
athophysiology of the
oronary Arteries After KD
n this issue of the Journal, Gordon et al. (10) review the
iterature concerning the histopathology of the coronary
rteries after KD. The hallmark of the coronary findings is
hat of intimal thickening, which may progress to localized
tenosis in coronary segments adjoining giant aneurysms.
hrombi within the aneurysms also may partially or totally
cclude the coronary vessel. In some cases, the obstructed
neurysm may recanalize, leaving various degrees of
bstruction. Severely injured coronary arteries may cal-
ify, further increasing the risk of chronic coronary
isease. Thus, patients with giant coronary aneurysms
econdary to KD are major candidates for coronary events
eyond childhood.
Intimal thickening also has been described in coronary
rteries with regressed aneurysms and in a few patients with
hat were considered to be normal coronary arteries based
n echocardiography. The authors of some studies have
escribed abnormal responses to vasodilatory agents in
oronary segments where aneurysms had regressed, but
ther investigators have failed to confirm this finding. It is
mportant to note that there have been no studies that
ndicate that these observations could be correlated with or
redictive of clinical events in former KD patients at any cge. Although concerns have been raised, there also is no
irect evidence that premature artherosclerosis is especially
rone to become superimposed on the typical Kawasaki
icopathology of the coronary arteries.
anagement of the Adult With KD
n their comprehensive review of the myocardial and car-
iovascular findings associated with KD, the authors con-
lude that “on the basis of the accumulating evidence, it is
ikely that patients with known aneurysms during the acute
hase of KD will have some cardiovascular morbidity as
oung adults.” This statement is true for patients with giant
neurysms, possibly true for some patients with large aneu-
ysms, but is not evidence based for those with small
neurysms, given the absence of late data showing that they
re in increased danger of clinical events in adult life. A rare
uspicious anecdote is not sufficient. The authors also state
hat “there is clearly a growing population of young adults
ith potentially important coronary artery disease after KD
uring childhood, and cardiologists specializing in adult
atients must be prepared to care for them.” The small
roup of patients who have residual giant aneurysms,
irtually all of whom having been recognized during child-
ood, will require care as adults, but there is evidence to
ndicate that their numbers are decreasing rather than
ncreasing. The patients who had small coronary aneurysms
r no aneurysms, who have not been shown to be in
eopardy for late complications, represent 99% of the KD
opulation.
The identification of KD survivors with large or giant
neurysms must be vigorously pursued, with appropriate
ollow-up visits and diagnostic studies as recommended by
he AHA guidelines (risk level IV and V) (11). Medical or
urgical management may be required. The group of pa-
ients who had small aneurysms that may or may not have
esolved represent 80% of the patients who had developed
neurysms after KD in the modern era, but only 4% of all
atients who had the disease. It is recommended by the
HA guidelines that these patients (risk level III) should be
reated with low-dose aspirin until aneurysms are docu-
ented to have regressed. It is also recommended that they
ave annual cardiology follow-up with noninvasive testing
with echocardiograms and electrocardiograms, as well as
iannual stress test/evaluation of myocardial perfusion
can). It could be argued that this degree of follow-up and
esting may be somewhat stringent when applied to all
atients in this category.
Patients with no coronary changes at any stage, and those
ith transient coronary ectasia that disappears within the
rst 6 to 8 weeks represent 95% of all individuals who had
D during childhood. The guidelines (risk levels I and II)
or these patients advocate cardiovascular risk assessment
ounseling at 5-year intervals. These patients have not been
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November 17, 2009:1921–3 The Risk of Late Coronary Eventshown to be at increased risk for cardiovascular events in
dulthood, and cardiologists must be aware that even such a
inimal follow-up recommendation may have a significant
ffect on men and women who have been looking at
hemselves as having had a benign childhood disease with
o significant concerns for late heart disease beyond what all
mericans face.
Psychiatrists tell us that being identified as a potential
chronic or high-risk heart patient” can affect patients’ sense
f their own vitality or longevity. Chronic background
nxiety will often lead to inappropriate and unnecessary
hanges in self-image and life style. Fear and emotion are
ikely to transcend the understanding of probabilities. The
ublished guidelines should never stand alone. They should
e reviewed individually and interpreted on a one-to-one
asis so that each post-KD individual will have a clear
erspective as to what is actually known about late risk in
is/her particular circumstance. The guidelines are simply
guidelines,” and as new information becomes available,
hey will undoubtedly be subject to future revisions. It is
ossible that the nature of this enigmatic disease may
hange over time, but at the present state of our knowledge,
t is important to avoid creating “patients” among individ-
als who have not been shown to be at increased late risk for
cardiac event.
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